ATC Group: C03CA01 Furosemide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C03CA01 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C03 Diuretics
3 C03C High-ceiling diuretics
4 C03CA Sulfonamides, plain
5 C03CA01 Furosemide

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 40 mg
PAREN - Parenteral 40 mg

Active ingredients in C03CA01

Active Ingredient Description
Furosemide

Furosemide inhibits active chloride transport in the thick ascending limb. Re-absorption of sodium, chloride from the nephron is reduced and a hypotonic or isotonic urine produced. The evidence from many experimental studies suggests that furosemide acts along the entire nephron with the exception of the distal exchange site.

Related product monographs

Title Information Source Document Type  
FRUSOL Oral solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FUROSEMIDE Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FUROSEMIDE TABLETS BP Uncoated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LASIX Solution for injection or infusion Health Products Regulatory Authority (IE) MPI, EU: SmPC
UREMIDE Tablet Marketing Authorisation Holder MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Albania (AL)

Australia (AU)

Austria (AT)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.